PTC Therapeutics, Inc.
PTCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070081
In the last 90 days, PTC Therapeutics, Inc. insiders filed 0 open-market purchases and 11 sales; 382 institutions reported holding it in 13F filings for Q2 2026, worth $8.20B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by PTC Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 11 filings
- 6 insiders, $13.7M in total
- Insiders trading
- 6
- Net value
- −$13.7M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for PTC Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Schmertzler Michael | Director | 1,296,594Indirect | Sep 18, 2026 | 6 |
| Boulding Mark Elliott | EXEC. VP AND CLO | 105,272 | Aug 19, 2026 | 14 |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | 383,868 | Aug 6, 2026 | 10 |
| Sollie-Zetlmayer Hege Elisabeth | Director | 52,526 | Jul 30, 2026 | 1 |
| Gravier Pierre | CHIEF FINANCIAL OFFICER | 83,986 | Jul 16, 2026 | 4 |
| Smith Mary L. | Director | 21,813 | Jul 13, 2026 | 2 |
| Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | 60,299 | Jul 13, 2026 | 14 |
| Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | 70,199 | Jun 22, 2026 | 5 |
| Pauwels Eric | CHIEF BUSINESS OFFICER | 73,411 | Jun 12, 2026 | 7 |
| Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | 79,115 | Apr 6, 2026 | 6 |
| Chutter Jessica Caroline | Director | 7,333 | Mar 26, 2026 | 1 |
| Okey Stephanie | Director | 8,000 | Mar 12, 2026 | 4 |
| Southwell David P | Director | 20,850 | Jan 6, 2026 | 1 |
| Steele Glenn Jr MD PhD | Director | 22,500 | Jan 6, 2026 | 1 |
| Zeldis Jerome B | Director | 22,500 | Jan 6, 2026 | 1 |
| Jacobson Allan Steven | Director | 21,451 | Jan 6, 2026 | 3 |
| Reeve Emma | Director | 10,666 | Jan 6, 2026 | 6 |
| Young Alethia | Director | 21,067 | Jan 6, 2026 | 1 |
| Bell William F. Jr. | Director | 10,333 | Feb 16, 2024 | 0 |
| Hill Emily Luisa | CHIEF FINANCIAL OFFICER | 38,925 | Mar 29, 2023 | 0 |
| Peltz Stuart Walter | CHIEF EXECUTIVE OFFICER | 54,903Indirect | Feb 2, 2023 | 0 |
| Svoronos Dawn | Director | 29,017 | Jun 10, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2022 (view filing) | Feb 1 | 2 days | Almstead Neil GregoryChief Technical Ops Officer | SSale | −27 | $40.00 | −$1.08K | −1.1%2.42K after | |
| Jan 27, 2022 (view filing) | Jan 25 | 2 days | Peltz Stuart WalterChief Executive Officer | SSale | −330 | $39.31 | −$13.0K | −0.8%39.0K after | |
| Jan 27, 2022 (view filing) | Jan 25 | 2 days | Pauwels EricChief Business Officer | SSale | −359 | $39.31 | −$14.1K | −0.7%51.0K after | |
| Jan 27, 2022 (view filing) | Jan 25 | 2 days | Hill Emily LuisaChief Financial Officer | SSale | −211 | $39.31 | −$8.29K | −0.6%37.7K after | |
| Jan 27, 2022 (view filing) | Jan 25 | 2 days | Almstead Neil GregoryChief Technical Ops Officer | SSale | −43 | $39.31 | −$1.69K | −1.7%2.45K after | |
| Jan 20, 2022 (view filing) | Jan 18 | 2 days | Utter Christine MarieSVP, Finance & CAO | SSale | −11.4K | $43.94 | −$502.1K | −30.2%26.4K after | 2 lots |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Utter Christine MarieSVP, Finance & CAO | SSale | −747 | $38.53 | −$28.8K | −4.4%16.3K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Almstead Neil GregoryChief Technical Ops Officer | SSale | −756 | $38.53 | −$29.1K | −2.1%35.1K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Almstead Neil GregoryChief Technical Ops Officer | SSale | −45 | $38.53 | −$1.73K | −2.6%1.71K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Boulding Mark ElliottExec. VP and CLO | SSale | −885 | $38.53 | −$34.1K | −1.8%47.5K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Hill Emily LuisaChief Financial Officer | SSale | −800 | $38.53 | −$30.8K | −3.5%22.3K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Klein Matthew B.Chief Operating Officer | SSale | −775 | $38.53 | −$29.9K | −4.5%16.5K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Pauwels EricChief Business Officer | SSale | −866 | $38.53 | −$33.4K | −2.4%34.5K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Peltz Stuart WalterChief Executive Officer | SSale | −1.87K | $38.53 | −$72.0K | −2.3%78.4K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Peltz Stuart WalterChief Executive Officer | SSale | −294 | $38.53 | −$11.3K | −1.3%22.5K after | |
| Jan 11, 2022 (view filing) | Jan 7 | 4 days | Svoronos DawnDirector | SSale | −510 | $38.53 | −$19.7K | −1.9%26.6K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Almstead Neil GregoryChief Technical Ops Officer | SSale | −64 | $41.16 | −$2.63K | −3.5%1.75K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Hill Emily LuisaChief Financial Officer | SSale | −173 | $41.16 | −$7.12K | −0.7%23.1K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Pauwels EricChief Business Officer | SSale | −806 | $41.16 | −$33.2K | −2.2%35.4K after | |
| Jan 6, 2022 (view filing) | Jan 4 | 2 days | Peltz Stuart WalterChief Executive Officer | SSale | −378 | $41.16 | −$15.6K | −1.6%22.8K after | |
| Sep 3, 2021 (view filing) | Sep 2 | 1 day | Boulding Mark ElliottExec. VP and CLO | SSale | −3.36K | $45.01 | −$151.4K | −6.5%48.4K after | |
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Okey StephanieDirector | SSale | −1.65K | $40.06 | −$66.1K | −63.1%963 after | |
| Jul 12, 2021 (view filing) | Jul 8-9 | 4 days | Boulding Mark ElliottExec. VP and CLO | SSale | −9.23K | $45.19 | −$417.3K | −16.0%48.4K after | 10 lots |